ConductScience.org, home

Paper52382

Antinuclear antibodies during procainamide treatment and drug acetylation.

Davies DM and 2 others. Br Med J, 1975. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Antinuclear antibodies during procainamide treatment and drug acetylation. Papers, record 52382. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/52382

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antinuclear antibodies during procainamide treatment and drug acetylation.
PubMed
Journal
Br Med J
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.27
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Davies DMD M
2Beedie MAM A
3Rawlins MDM D

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, AntinuclearMajor topic
IsoniazidMajor topic
ProcainamideMajor topic
Acetylation
Adult
Aged
Female
Humans
Male
Middle Aged
Neutrophils

Source PubMed

Download CSV of topics

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14623713Metabolism of procainamide in rhesus monkey and man.Clin Pharmacol Ther1972https://conductscience.org/library/papers/4623713PubMed
24145853Systemic lupus erythematosus syndrome induced by practolol.Br Med J1973https://conductscience.org/library/papers/4145853PubMed
314314965THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE.Clin Pharmacol Ther1965https://conductscience.org/library/papers/14314965PubMed
413820968Genetic control of isoniazid metabolism in man.Br Med J1960https://conductscience.org/library/papers/13820968PubMed
513722334Peripheral neuritis due to isoniazid.Bull World Health Organ1960https://conductscience.org/library/papers/13722334PubMed
74912962Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine.J Lab Clin Med1970https://conductscience.org/library/papers/4912962PubMed
85554939The polymorphic acetylation of dapsone in man.Clin Pharmacol Ther1971https://conductscience.org/library/papers/5554939PubMed
95638098The actylation of sulamethazine and sulfamethoxypyridazine by human subjects.Clin Pharmacol Ther1968https://conductscience.org/library/papers/5638098PubMed

Download CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
24902607Pharmacological regulators of autophagy and their link with modulators of lupus disease.Br J Pharmacol2014https://conductscience.org/library/papers/24902607PubMed
7011656Acetylator phenotype and lupus erythematosus.Clin Pharmacokinet1981https://conductscience.org/library/papers/7011656PubMed
6849749Effects of therapeutic drugs on lymphocyte transformation.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6849749PubMed
6198178Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6198178PubMed
6103797Antinuclear antibodies and cardiovascular drugs.Drugs1980https://conductscience.org/library/papers/6103797PubMed
2859977Genetically determined variability in acetylation and oxidation. Therapeutic implications.Drugs1985https://conductscience.org/library/papers/2859977PubMed
911600Adverse reactions to procainamide.Br J Clin Pharmacol1977https://conductscience.org/library/papers/911600PubMed
346289Clinical pharmacokinetics of procainamide.Clin Pharmacokinet1978https://conductscience.org/library/papers/346289PubMed
328206Disease and acetylation polymorphism.Clin Pharmacokinet1977https://conductscience.org/library/papers/328206PubMed
17431Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction.Br J Ophthalmol1977https://conductscience.org/library/papers/17431PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/52382

GET https://conductscience.org/api/papers/v1/52382/authors